Browse Items (2 total)

This chapter discusses the rationale for developing multimodal or multifunctional drugs (also called designed multiple ligands or DMLs) aimed at disease-modifying treatment strategies for the most common neurodegenerative diseases Alzheimer's and…

Output Formats

atom, dcmes-xml, json, omeka-xml, rss2